Jump to navigation
The University of Arizona ranked No. 22 among the top U.S. universities granted utility patents in 2022, according to a list published by the National Academy of Inventors.
The new molecules exploit the iron dependency of malignant cells and could lead to the development of new anticancer drugs.
CatSat is a small satellite carrying a new communications concept – an inflatable antenna – into space. Led by UArizona students and supported by engineers from local aerospace companies, the project offers students a rare chance to get hands-on experience with spaceflight technology.
Floyd "Ski" Chilton, a professor of nutritional sciences and director of the university's Center for Precision Nutrition and Wellness, has received the highest professional distinction awarded to academic inventors.
Research on the drug, known as DYR533, was conducted at the the University of Arizona R. Ken Coit College of Pharmacy and BIO5 Institute, in partnership with the Biodesign Institute in Phoenix.
Triple-negative breast cancer accounts for about 10 to 15% of all breast cancers. Researchers have developed a drug they hope can treat it with little to no toxic side effects.
Yeast cells and human immune system cells rely on similar chemical reactions to know when to grow. Scientists have identified differences between the cell types that could help with the development of antifungal drugs.
The university held this same position in the 2020 report, indicating continued productivity in driving impact from research and innovation. The university had 86 patents issued last year.
Tech Launch Arizona, the university's commercialization arm, recorded 303 novel inventions between July 1, 2021, and June 30 – the most invention disclosures registered for a single year in UArizona history.
